Welltower Inc. (NYSE: WELL), an S&P 500 company, is one of the world's preeminent residential wellness and healthcare infrastructure companies. We seek to position our portfolio of 1,500+ seniors and wellness housing communities at the intersection of housing, healthcare, and hospitality, creating vibrant communities for mature renters and older adults in the United States, United Kingdom, and Canada. We also strive to support physicians in our outpatient medical buildings with the critical infrastructure needed to deliver quality care. We believe our real estate portfolio is unmatched, located in highly attractive micro-markets with stunning built environments. Yet, we are an unusual real estate organization as we view ourselves as a product company in a real estate wrapper, driven by relationships and an unconventional culture. Through our disciplined approach to capital allocation powered by our Data Science platform and superior operating results driven by our operating platform, the Welltower Business System, we aspire to deliver long-term compounding of per share growth and returns for our existing investors – our North Star.
Demographic Tailwinds | Explore how Welltower capitalizes on the aging population trend, driving demand for senior housing and healthcare services across its diverse portfolio |
Acquisition Strategy | Delve into Welltower's aggressive investment approach, leveraging its "flywheel" effect to pursue accretive acquisitions and outpace competitors |
Operational Excellence | Learn about Welltower's focus on improving efficiencies, particularly in its Senior Housing Operating Portfolio, contributing to strong performance |
Market Outlook | Analyst price targets range from $115 to $190, with projections of sustainable double-digit growth through 2026 and sector-leading FFO growth |
Metrics to compare | WELL | Sector Sector - Average of metrics from a broad group of related Real Estate sector companies | Relationship RelationshipWELLPeersSector | |
---|---|---|---|---|
P/E Ratio | 92.6x | 33.1x | 8.5x | |
PEG Ratio | 0.83 | 12.32 | 0.01 | |
Price/Book | 3.0x | 2.0x | 0.9x | |
Price / LTM Sales | 11.7x | 8.5x | 3.7x | |
Upside (Analyst Target) | 9.7% | 11.0% | 14.7% | |
Fair Value Upside | Unlock | −5.1% | 2.6% | Unlock |